These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26143971)

  • 41. Effects of human opiorphin on food intake and water intake in mice following central administration.
    Chen Y; Tian XZ; Bai L; Liu ZQ; Xiao XP; Liu P; Li XK
    Neurosci Lett; 2017 Feb; 641():62-69. PubMed ID: 28104434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Identification of human opiorphin, a natural antinociceptive modulator of opioid-dependent pathways].
    Rougeot C; Messaoudi M
    Med Sci (Paris); 2007 Jan; 23(1):37-9. PubMed ID: 17212930
    [No Abstract]   [Full Text] [Related]  

  • 43. Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model.
    Labus J; Häckel S; Lucka L; Danker K
    J Neurosci Methods; 2014 May; 228():35-45. PubMed ID: 24631939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
    Vanderah TW; Largent-Milnes T; Lai J; Porreca F; Houghten RA; Menzaghi F; Wisniewski K; Stalewski J; Sueiras-Diaz J; Galyean R; Schteingart C; Junien JL; Trojnar J; Rivière PJ
    Eur J Pharmacol; 2008 Mar; 583(1):62-72. PubMed ID: 18282565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pericyte abundance affects sucrose permeability in cultures of rat brain microvascular endothelial cells.
    Parkinson FE; Hacking C
    Brain Res; 2005 Jul; 1049(1):8-14. PubMed ID: 15935996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
    Lu W; Tan YZ; Jiang XG
    Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of an immortalized human (hBMEC) in vitro blood-brain barrier model.
    Eigenmann DE; Jähne EA; Smieško M; Hamburger M; Oufir M
    Anal Bioanal Chem; 2016 Mar; 408(8):2095-107. PubMed ID: 26790872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro evidence for the brain glutamate efflux hypothesis: brain endothelial cells cocultured with astrocytes display a polarized brain-to-blood transport of glutamate.
    Helms HC; Madelung R; Waagepetersen HS; Nielsen CU; Brodin B
    Glia; 2012 May; 60(6):882-93. PubMed ID: 22392649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides.
    Elmagbari NO; Egleton RD; Palian MM; Lowery JJ; Schmid WR; Davis P; Navratilova E; Dhanasekaran M; Keyari CM; Yamamura HI; Porreca F; Hruby VJ; Polt R; Bilsky EJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):290-7. PubMed ID: 15166257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro porcine blood-brain barrier model for permeability studies: pCEL-X software pKa(FLUX) method for aqueous boundary layer correction and detailed data analysis.
    Yusof SR; Avdeef A; Abbott NJ
    Eur J Pharm Sci; 2014 Dec; 65():98-111. PubMed ID: 25239510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
    Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
    Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
    Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From the Cover: In Vitro and In Vivo Blood-Brain Barrier Penetration Studies with the Novel Cyanide Antidote Candidate Dimethyl Trisulfide in Mice.
    Kiss L; Bocsik A; Walter FR; Ross J; Brown D; Mendenhall BA; Crews SR; Lowry J; Coronado V; Thompson DE; Sipos P; Szabó-Révész P; Deli MA; Petrikovics I
    Toxicol Sci; 2017 Dec; 160(2):398-407. PubMed ID: 28973547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier.
    Walter FR; Veszelka S; Pásztói M; Péterfi ZA; Tóth A; Rákhely G; Cervenak L; Ábrahám CS; Deli MA
    J Neurochem; 2015 Sep; 134(6):1040-54. PubMed ID: 26112237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
    Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
    Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.
    Liu HM; Liu XF; Yao JL; Wang CL; Yu Y; Wang R
    J Pharmacol Exp Ther; 2006 Oct; 319(1):308-16. PubMed ID: 16803861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration.
    Fichna J; Mazur M; Grzywacz D; Kamysz W; Perlikowska R; Piekielna J; Sobczak M; Sałaga M; Toth G; Janecka A; Chen C; Olczak J
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6673-6. PubMed ID: 24220171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
    Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.
    Greene DL; Hau VS; Abbruscato TJ; Bartosz H; Misicka A; Lipkowski AW; Hom S; Gillespie TJ; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1366-75. PubMed ID: 8667199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
    Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
    Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.